Institute Of Hematology & Blood Diseases Hospital, China

This early-stage study tested a drug called Linperlisib in 4 adults with autoimmune hemolytic anemia (AIHA) whose disease did not respond to at least two prior treatments. The goal was to see if the drug could improve red blood cell counts and reduce symptoms. The study was termi…

This study tested whether a combination of venetoclax and azacytidine (or a standard chemo regimen) could prevent relapse in adults with acute myeloid leukemia (AML) who still had signs of the disease after initial treatment. The 20 participants were in remission but had measurab…

This early-phase study tested a new cell therapy (LCAR-AMDR cells) in 4 people with acute myeloid leukemia that had come back or not responded to standard treatments. The therapy uses specially engineered immune cells to target two proteins on leukemia cells. The study was termin…

This study tested a low-dose chemotherapy drug called decitabine in people with a severe type of anemia (aplastic anemia) that did not get better with standard treatments. The goal was to see if the drug could improve blood cell counts. Only 3 people were enrolled before the stud…

This study aimed to find how often IDH1/2 gene mutations occur in adults with acute myeloid leukemia (AML) and how these mutations affect patient outcomes. Researchers analyzed stored leukemia samples from over 1,000 patients. The goal was to better understand the disease, not to…